Glynn v. Merck Sharp & Dohme Corp.

OPINION

PISANO, District Judge.

Plaintiffs Bernadette Glynn and Richard Glynn (“Plaintiffs”) brought this lawsuit against Defendant Merck, Sharp, & Dohme Corp. (“Defendant”), the manufacturer of Fosamax, which is a drug approved by the United States Food and Drug Administration (“FDA”) for the treatment and prevention of osteoporosis. This matter is part of the multi-district litigation (“MDL”) concerning Fosamax and involves allegations that Fosamax causes atypical femur fractures (“AFFs1”), it caused Plaintiff Mrs. Glynn’s femur fracture, and Defendant failed to warn physicians about Fosamax…